EVEROLIMUS

Everolimus

What it is

Everolimus is a medication that belongs to the class of mTOR (mammalian target of rapamycin) inhibitors. It works by blocking a protein pathway that regulates cell growth, division, and survival. Because of this, Everolimus is widely used both as an immunosuppressant to prevent organ transplant rejection and as an anti-cancer agent in certain malignancies.

Uses

Everolimus is prescribed for multiple medical conditions, including:

• Organ Transplantation: To prevent rejection of kidney and liver transplants by suppressing the immune system.
• Oncology: For treatment of cancers such as advanced kidney cancer (renal cell carcinoma), breast cancer, neuroendocrine tumors, and subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis.
• Other Conditions: Used in certain genetic disorders such as tuberous sclerosis complex to manage tumors.

When It May Be Recommended

Doctors may recommend Everolimus if you are a transplant recipient needing long-term immunosuppressive therapy, or if you are diagnosed with cancers that are responsive to mTOR inhibition. It is also considered in patients with specific tumor syndromes where other treatments are not effective.

Abnormal Results / Monitoring

Since Everolimus has a narrow therapeutic window, blood levels are often monitored to ensure effectiveness and minimize toxicity. Abnormal results may indicate:

• Low Everolimus Levels: Risk of organ transplant rejection or reduced cancer treatment effectiveness.
• High Everolimus Levels: Increased risk of side effects such as infections, mouth ulcers, high cholesterol, anemia, or impaired kidney function.

Risks and Side Effects

Potential side effects of Everolimus include mouth sores, infections, fatigue, delayed wound healing, high blood sugar, high cholesterol, anemia, or kidney dysfunction. Regular monitoring of blood counts, kidney function, liver enzymes, and lipid levels is required during therapy.